Cygenta
Latest round
- Series A
Last raised
- Feb 2026
Total raised
- Undisclosed
Investors
- 2
About Cygenta
, trading as Cygenta, is a biotechnology service company.more than 8,000 square meters of cGMP facilities. The company’s main business is offering end-to-end CDMO solutions for cell and gene therapies, including process development, quality control, and GMP production of plasmids, viral vectors, and cell-based therapeutics. The company’s self-developed platforms cover high-yield plasmid fermentation (5–200 L), scalable viral vector production (3–200 L), and flexible cell therapy manufacturing for both autologous and allogeneic applications. Its products are used in the field of gene and cell therapy drug development. The company generates revenue by providing fee-for-service CDMO solutions, including process optimization, analytical method development, GMP production of plasmids/viruses/cell products, and regulatory support, complemented by facility leasing and quality control testing for biopharma partners.
Who invested in Cygenta
2 investors across 1 round
See all investors in Cygenta
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 9, 2026
Amount
Undisclosed
Investors
Questions about Cygenta
Who invested in Cygenta?
Cygenta has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cygenta raised?
Cygenta has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cygenta last raise money?
Cygenta's most recent round on record is a Series A, in Feb 2026.
What does Cygenta do?
, trading as Cygenta, is a biotechnology service company.
Where is Cygenta headquartered?
Cygenta is headquartered in Beijing, China.
Which VCs invest in companies like Cygenta?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Cygenta's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cygenta? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.